Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture

Clinical trial NCT05106517 · UNKNOWN

Trial details

NCT number: NCT05106517
Sponsor: Shenzhen People's Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Denosumab vs Zoledronate

Start date: 2021-09-08
Primary completion: 2023-03-05
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.